Testing tumor samples to find new treatments based on DNA changes
Treatments studied
Part of Cancer clinical trials.
This trial takes a sample of your tumor during a standard procedure to grow it in a lab and test different drugs. The goal is to find which drugs might work best for people with your specific tumor DNA change.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- Your tumor must have a specific DNA change that the study team thinks is important.
- Your cancer must be locally advanced or metastatic (spread), and you need a scheduled biopsy or surgery as part of your usual care.
- The tumor sample must be large enough to share with the research lab.
- You must have normal blood clotting (INR under 1.5) and enough platelets (over 50,000).
- You cannot be on certain blood thinners that cannot be paused safely before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This trial looks for the specific DNA or tumor changes in your cancer and then matches you to a targeted drug plan. It’s meant for people with early cancer that has not already been treated in this study.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
Hear when a new Neoplasm Malignant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.